FDA Approves Combo of Opdivo Plus Yervoy for Advanced Liver Cancer

The CheckMate-9DW trial showed significant overall survival benefit versus lenvatinib or sorafenib
liver
Adobe Stock
Published on
Updated on
Loading content, please wait...

Related Stories

No stories found.
logo
www.healthday.com